Financials Aminologics Co.,Ltd.

Equities

A074430

KR7074430000

Pharmaceuticals

End-of-day quote Korea S.E. 23:00:00 13/06/2024 BST 5-day change 1st Jan Change
1,426 KRW -1.45% Intraday chart for Aminologics Co.,Ltd. -4.49% +6.10%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 150,623 171,701 236,254 192,780 160,723 118,039
Enterprise Value (EV) 1 129,735 148,790 212,551 168,770 133,474 91,360
P/E ratio 18.8 x -143 x 110 x 36 x -22.1 x 48.5 x
Yield - - - - - -
Capitalization / Revenue 8.16 x 9.05 x 13.4 x 8.44 x 5.88 x 5.65 x
EV / Revenue 7.03 x 7.84 x 12 x 7.39 x 4.88 x 4.37 x
EV / EBITDA 17.4 x -268 x 75.6 x 39.9 x 18.4 x 47.9 x
EV / FCF 30.5 x 33.1 x 1,924 x -107 x 163 x -45.6 x
FCF Yield 3.28% 3.02% 0.05% -0.93% 0.61% -2.19%
Price to Book 2.83 x 3.31 x 4.41 x 3.25 x 3.13 x 2.17 x
Nbr of stocks (in thousands) 87,827 87,827 87,827 87,827 87,827 87,827
Reference price 2 1,715 1,955 2,690 2,195 1,830 1,344
Announcement Date 19/03/19 16/03/20 15/03/21 21/03/22 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 18,450 18,980 17,651 22,849 27,337 20,887
EBITDA 1 7,469 -555.7 2,811 4,232 7,259 1,908
EBIT 1 7,334 -822.3 2,584 3,953 6,908 1,462
Operating Margin 39.75% -4.33% 14.64% 17.3% 25.27% 7%
Earnings before Tax (EBT) 1 7,982 -1,201 2,074 3,704 -6,281 2,291
Net income 1 7,996 -1,201 2,140 5,360 -7,282 2,436
Net margin 43.34% -6.33% 12.12% 23.46% -26.64% 11.66%
EPS 2 91.05 -13.67 24.37 61.03 -82.91 27.74
Free Cash Flow 1 4,250 4,495 110.5 -1,572 819.1 -2,002
FCF margin 23.04% 23.68% 0.63% -6.88% 3% -9.59%
FCF Conversion (EBITDA) 56.9% - 3.93% - 11.28% -
FCF Conversion (Net income) 53.15% - 5.16% - - -
Dividend per Share - - - - - -
Announcement Date 19/03/19 16/03/20 15/03/21 21/03/22 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 20,888 22,912 23,703 24,010 27,249 26,680
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 4,250 4,495 110 -1,572 819 -2,002
ROE (net income / shareholders' equity) 16.3% -2.29% 4.06% 9.49% -13.1% 4.6%
ROA (Net income/ Total Assets) 8.63% -0.9% 2.74% 3.94% 7.15% 1.61%
Assets 1 92,656 133,933 78,121 135,978 -101,883 150,968
Book Value Per Share 2 606.0 590.0 610.0 676.0 585.0 620.0
Cash Flow per Share 2 133.0 92.70 97.70 101.0 145.0 137.0
Capex 1 231 100 309 516 490 156
Capex / Sales 1.25% 0.53% 1.75% 2.26% 1.79% 0.75%
Announcement Date 19/03/19 16/03/20 15/03/21 21/03/22 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A074430 Stock
  4. Financials Aminologics Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW